|
ข่าวต่างประเทศ |
|
e! Science News - Latest science news
|
|
-
Personality test finds some mouse lemurs shy, others bold
pAnyone who has ever owned a pet will tell you that it has a unique personality./p
pa href=http://esciencenews.com/articles/2013/06/18/personality.test.finds.some.mouse.lemurs.shy.others.boldread more/a/p
-
Chemical probe confirms that body makes its own rotten egg gas, H2S, to benefit health
pA new study confirms directly what scientists previously knew only indirectly: The poisonous quot;rotten eggquot; gas hydrogen sulfide is generated by our body's growing cells./p
pa href=http://esciencenews.com/articles/2013/06/18/chemical.probe.confirms.body.makes.its.own.rotten.egg.gas.h2s.benefit.healthread more/a/p
-
Small dam construction to reduce greenhouse emissions is causing ecosystem disruption
pResearchers conclude in a new report that a global push for small hydropower projects, supported by various nations and also the Kyoto Protocol to reduce greenhouse gas emissions, may cause unanticipated and potentially significant losses of habitat and biodiversity./p
pa href=http://esciencenews.com/articles/2013/06/18/small.dam.construction.reduce.greenhouse.emissions.causing.ecosystem.disruptionread more/a/p
-
Seismic gap outside of Istanbul
pEarthquake researchers have now identified a 30 kilometers long and ten kilometers deep area along the North Anatolian fault zone just south of Istanbul that could be the starting point for a strong earthquake. The group of seismologists including Professor Marco Bohnhoff of the GFZ German Research Centre for Geosciences reported in the current online issue of the scientific journal emNature Communications/em that this potential earthquake source is only 15 to 20 kilometers from the historic city center of Istanbul./p
pa href=http://esciencenews.com/articles/2013/06/18/seismic.gap.outside.istanbulread more/a/p
-
An article in 'Cell' reveals a new resistance mechanism to chemotherapy in breast and ovarian cancer
pIt is estimated that between 5% and 10% of breast and ovarian cancers are familial in origin, which is to say that these tumours are attributable to inherited mutations from the parents in genes such as BRCA1 or BRCA2. In patients with these mutations, PARP inhibitors, which are currently in clinical trials, have shown encouraging results that make them a new option for personalised cancer treatment, an alternative to standard chemotherapy. Nevertheless, the latest studies indicate that a fraction of these patients generate resistance to the drug and, therefore, stop responding to the new treatment./p
pa href=http://esciencenews.com/articles/2013/06/18/an.article.cell.reveals.a.new.resistance.mechanism.chemotherapy.breast.and.ovarian.cancerread more/a/p
|
|
